Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Gardner

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Oncotarget|September 10, 2019
Development and analytical validation of a next-generation sequencing based microsatellite instability (MSI) assaySarabjot Pabla, Jonathan Andreas, Felicia L Lenzo, et al.
The Journal of Biological Chemistry|April 6, 2018
The proinflammatory protein HMGB1 is a substrate of transglutaminase-2 and forms high-molecular weight complexes with autoantigensWilliam L Willis, Linan Wang, Takuma Tsuzuki Wada, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2011
Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure-activity relationship (SAR)M Abid Masood, Matthew D Selby, Andrew S Bell, et al.
Oncotarget|December 3, 2016
Robust detection of immune transcripts in FFPE samples using targeted RNA sequencingBenjamin E Paluch, Sean T Glenn, Jeffrey M Conroy, et al.
The Journal of Molecular Diagnostics : JMD|October 25, 2017
Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid TumorsJeffrey M Conroy, Sarabjot Pabla, Sean T Glenn, et al.
ACS Infectious Diseases|April 21, 2023
Perspective on Schistosomiasis Drug Discovery: Highlights from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection, London, September 2022Nicola Caldwell, Rana Afshar, Beatriz Baragaña, et al.
Oncotarget|August 7, 2019
Oncologist uptake of comprehensive genomic profile guided targeted therapyMary K Nesline, Paul DePietro, Grace K Dy, et al.
Journal of Medicinal Chemistry|July 1, 2025
Thioquinazolinones as Antituberculosis Agents Targeting Phosphopantetheinyl TransferaseAmrita Singh, Logan T Zwerneman, Kyle Planck, et al.
Science Advances|March 15, 2024
Redirecting raltitrexed from cancer cell thymidylate synthase to <i>Mycobacterium tuberculosis</i> phosphopantetheinyl transferaseAmrita Singh, Samantha Ottavi, Inna Krieger, et al.
Journal for Immunotherapy of Cancer|May 11, 2018
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burdenCarl Morrison, Sarabjot Pabla, Jeffrey M Conroy, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Oncotarget|September 10, 2019
Development and analytical validation of a next-generation sequencing based microsatellite instability (MSI) assaySarabjot Pabla, Jonathan Andreas, Felicia L Lenzo, et al.
The Journal of Biological Chemistry|April 6, 2018
The proinflammatory protein HMGB1 is a substrate of transglutaminase-2 and forms high-molecular weight complexes with autoantigensWilliam L Willis, Linan Wang, Takuma Tsuzuki Wada, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2011
Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure-activity relationship (SAR)M Abid Masood, Matthew D Selby, Andrew S Bell, et al.
Oncotarget|December 3, 2016
Robust detection of immune transcripts in FFPE samples using targeted RNA sequencingBenjamin E Paluch, Sean T Glenn, Jeffrey M Conroy, et al.
The Journal of Molecular Diagnostics : JMD|October 25, 2017
Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid TumorsJeffrey M Conroy, Sarabjot Pabla, Sean T Glenn, et al.
ACS Infectious Diseases|April 21, 2023
Perspective on Schistosomiasis Drug Discovery: Highlights from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection, London, September 2022Nicola Caldwell, Rana Afshar, Beatriz Baragaña, et al.
Oncotarget|August 7, 2019
Oncologist uptake of comprehensive genomic profile guided targeted therapyMary K Nesline, Paul DePietro, Grace K Dy, et al.
Journal of Medicinal Chemistry|July 1, 2025
Thioquinazolinones as Antituberculosis Agents Targeting Phosphopantetheinyl TransferaseAmrita Singh, Logan T Zwerneman, Kyle Planck, et al.
Science Advances|March 15, 2024
Redirecting raltitrexed from cancer cell thymidylate synthase to <i>Mycobacterium tuberculosis</i> phosphopantetheinyl transferaseAmrita Singh, Samantha Ottavi, Inna Krieger, et al.
Journal for Immunotherapy of Cancer|May 11, 2018
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burdenCarl Morrison, Sarabjot Pabla, Jeffrey M Conroy, et al.
Pageof 5